Valuation (10%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | -50.85 | -32.75 |
PEG Ratio (TTM) | -13.48 | -2.62 |
P/S Ratio (TTM) | N/A | 35.22 |
P/B Ratio (TTM) | 1.01 | 6.92 |
P/FCF Ratio (TTM) | -46.94 | -188.65 |
Price to 5YR AVG Earnings Ratio | N/A | -29.46 |
Price to 5YR AVG FCF Ratio | N/A | -26.95 |
Profitability (0%) |
Company | Industry |
---|---|---|
ROA (TTM) | -1.88% | 47.25% |
ROE (TTM) | -0.66% | -531.49% |
Net Profit Margin (TTM) | N/A | -264.51% |
ROIC 5YR AVG | N/A | 831.75% |
Growth (0%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | -1,722.86% | -5,764.75% | N/A |
Revenue | -30.27% | N/A | N/A |
Net Income | -1,401.04% | -7,337.69% | N/A |
Cash Flow | -1,284.29% | -10,283.98% | N/A |
Health (35%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | 0.20 | 4.81 |
Quick Ratio (TTM) | 19.25 | 24.14 |
D/E Ratio (TTM) | 0.01 | 0.23 |
Interest Coverage (TTM) | 1.08 | 2.74 |
Piotroski F-Score | 3 | 3 |
Altman Z-Score | 0.63 | 21.22 |
LTL to 5YR AVG FCF | N/A | -1.27 |
Shares Outstanding Growth 5YR AVG | N/A | 515.61% |